Fezolinetant in the treatment of vasomotor symptoms associated with menopause: a profile of its use Hannah A. Blair Adis Drug Q&A 27 May 2024
Dietary supplements may boost memory, but more evidence is required Connie Kang Practical Issues and Updates 15 May 2024
Increasing patient safety due to an implemented ward pharmacist in an interprofessional cancer care team evaluated in a prospective, controlled intervention study Svenja DierkesAnnette FreidankRoland Radziwill Original Research Article 29 April 2024 Pages: 151 - 159
Correction to: Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA Hannah A. Blair Correction Open access 28 April 2024 Pages: 172 - 172
Assessment of rational antibiotic use among children being treated in primary care facilities in Punjab, Pakistan: findings and implications Zia Ul MustafaAmer Hayat KhanBrian Godman Original Research Article 28 April 2024 Pages: 160 - 171
Adjust antimicrobial agent regimens in older patients to correct for changes in pharmacokinetics and to avoid adverse events Simon Fung Drug Reactions and Interactions 28 April 2024 Pages: 145 - 150
Determine and remove the drug trigger, usually antibiotics, that causes acute generalised exanthematous pustulosis Esther S. KimConnie Kang Drug Reactions and Interactions 28 April 2024 Pages: 141 - 144
Adis Summary of Research: Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder Yahiya Y. Syed Adis Summary of Research 06 May 2024 Pages: 139 - 140
Sparsentan in immunoglobulin A nephropathy: a profile of its use Young-A HeoConnie Kang Adis Drug Q&A 29 March 2024 Pages: 101 - 108
What is the role of pioglitazone for patients with type 2 diabetes in value-based care settings? Andrea BushTina BennyMatthew Seamon Current Opinion 28 March 2024 Pages: 131 - 136
Treating paediatric Crohn’s disease is challenging but new treatments hold promise Tina Nie Disease Management 28 March 2024 Pages: 121 - 126
Correction to: Efanesoctocog alfa in hemophilia A: a profile of its use Simon FungHannah A. Blair Correction Open access 21 March 2024 Pages: 138 - 138
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use Tina Nie Correction Open access 21 March 2024 Pages: 137 - 137
Be aware of the risks of nephrotoxicity when prescribing amoxicillin and third-generation cephalosporins Amy Zhuang-Yan Drug Reactions and Interactions 21 March 2024 Pages: 127 - 130
Treat bipolar depression with atypical antipsychotics and mood stabilisers; new therapies require further study Simon Fung Practical Issues and Updates 11 March 2024 Pages: 109 - 114
Get on top of gout with a fresh look at treatment options Caroline FentonConnie Kang Practical Issues and Updates 04 April 2024 Pages: 115 - 120
Evaluation of diclofenac utilization patterns before and after digital risk minimization intervention in outpatient settings in Montenegro Maja StankovicNemanja TurkovicNemanja Rancic Original Research Article 24 February 2024 Pages: 90 - 100
Multisite primary care led amoxicillin challenge pathway to safely remove penicillin allergy label David C. MariKelley M. HensonTaylor A. Banks Therapy in Practice 10 March 2024 Pages: 83 - 89
Administer antidepressants during pregnancy on a case-by-case basis Yvette N. LambSimon Fung Practical Issues and Updates 10 March 2024 Pages: 78 - 82
Metformin reduces the complications of gestational diabetes mellitus but its long-term effects on offspring require further study Simon Fung Practical Issues and Updates 10 March 2024 Pages: 72 - 77
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA Hannah A. Blair Adis Drug Q&A Open access 15 March 2024 Pages: 61 - 71
Mirvetuximab soravtansine in folate receptor alpha-positive, platinum-resistant ovarian cancers: a profile of its use Simon FungYahiya Y. Syed Adis Drug Q&A 10 March 2024 Pages: 53 - 60
Pirtobrutinib in relapsed or refractory mantle cell lymphoma: a profile of its use Young-A Heo Adis Drug Q&A 27 January 2024 Pages: 45 - 52
Preferably pre-empt pathological scars, or pick from a plethora of therapies Caroline FentonYvette N. Lamb Practical Issues and Updates 08 January 2024 Pages: 22 - 26
Correction to: Tezepelumab in severe asthma: a profile of its use Yahiya Y. Syed Correction Open access 05 January 2024 Pages: 43 - 43
Platelet-rich plasma therapy for chronic cutaneous wounds stratified by etiology: a systematic review of randomized clinical trials Verónica Salgado-PachecoMontserrat Serra-MasMarta Otero-Viñas Systematic Review Open access 28 February 2024 Pages: 31 - 42
Expand the treatment horizon of premenstrual dysphoric disorder with targeted therapeutic approaches Young-A Heo Practical Issues and Updates 24 February 2024 Pages: 27 - 30
Treat borderline personality disorder with psychotherapy and concomitant psychiatric disorders with adjuvant pharmacotherapy Esther S. KimYvette N. Lamb Disease Management 24 February 2024 Pages: 17 - 21
Efanesoctocog alfa in hemophilia A: a profile of its use Simon FungHannah A. Blair Adis Drug Q&A Open access 24 February 2024 Pages: 9 - 16
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use Tina Nie Adis Drug Q&A Open access 24 February 2024 Pages: 1 - 8
Nirsevimab in the prevention of respiratory syncytial virus lower respiratory tract disease: a profile of its use Matt Shirley Adis Drug Q&A 22 December 2023 Pages: 413 - 420
The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients Elisabetta MunzoneAlessandra FabiMichelino De Laurentiis Original Research Article Open access 21 December 2023 Pages: 432 - 446
Understand the benefits and risks of intravenous methadone for perioperative and chronic cancer pain management Tina Nie Practical Issues and Updates 13 December 2023 Pages: 426 - 431
Tezepelumab in severe asthma: a profile of its use Yahiya Y. Syed Adis Drug Q&A Open access 07 December 2023 Pages: 393 - 403
Spesolimab in generalised pustular psoriasis flares: a profile of its use Tina Nie Adis Drug Q&A 02 December 2023 Pages: 404 - 412
Correction to: RBX2660 (REBYOTA®) in preventing recurrence of Clostridioides difficile infection: a profile of its use in the USA Hannah A. Blair Correction Open access 24 November 2023 Pages: 447 - 447
Manage vitiligo with a personalised approach: consider old and new treatments Nicole L. France Disease Management 24 November 2023 Pages: 421 - 425
The role of belzutifan, an inhibitor of hypoxia-inducible factor, for renal cell carcinoma in adults with Von Hippel–Lindau disease: a review Anne M. SchwartzWaddih FakhreAlan D. Kaye Review Article 21 November 2023 Pages: 388 - 392
Ublituximab in relapsing forms of multiple sclerosis: a profile of its use Hannah A. Blair Adis Drug Q&A 06 November 2023 Pages: 365 - 372
Deucravacitinib in plaque psoriasis: a profile of its use Arnold Lee Adis Drug Q&A 01 November 2023 Pages: 357 - 364
Towards intra-articular therapies for more than just symptom management in osteoarthritis Simon Fung Practical Issues and Updates 09 October 2023 Pages: 382 - 387
Manage idiopathic hypersomnia with a combination of non-pharmacological and pharmacological treatments Arnold Lee Practical Issues and Updates 03 October 2023 Pages: 378 - 381
First reports of adverse drug reactions First reports of adverse drug reactions 29 September 2023 Pages: 353 - 353
Go with your gut: targeting the microbiome for treatment of irritable bowel syndrome Simon Fung Disease Management 23 September 2023 Pages: 373 - 377
RBX2660 (REBYOTA®) in preventing recurrence of Clostridioides difficile infection: a profile of its use in the USA Hannah A. Blair Adis Drug Q&A Open access 23 September 2023 Pages: 331 - 338
Prescribe colchicine with care and be aware of colchicine drug interactions Amy Zhuang-YanConnie Kang Drug Reactions and Interactions 22 September 2023 Pages: 348 - 352
Addressing the opioid epidemic in Pakistan: urgent need for opioid stewardship and comprehensive solutions Adeel SiddiquiSunil ShresthaOmar Akhlaq Bhutta Commentary 05 September 2023 Pages: 354 - 356
Nails blue? Don’t be sad, the cause may be discoverable Arnold Lee Drug Reactions and Interactions 30 August 2023 Pages: 344 - 347
Treat functional constipation in children with conventional options first and consider alternatives if needed Tina Nie Practical Issues and Updates 28 August 2023 Pages: 339 - 343
